Trivarx (ASX:TRI)
ASX announcement history & article coverage
Transparent by design.
Announcments by Trivarx (ASX:TRI) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Letter to Shareholders & Notice of AGM & Proxy Form
Syntro Health Appointed to Support Stabl-Im Clinical Program
TrivarX engages Syntro Health to advance Stabl-Im clinical trial preparations
Change of Director's Interest Notice - David Trimboli
Change of Director's Interest Notice - Chris Ntoumenopoulos
Notification of cessation of securities - TRI
Appendix 4G
Corporate Governance Statement
2026 Annual Report
TrivarX shifts focus to Stabl-Im MRI platform after $8.76m FY2026 loss and going concern warning
Stabl-Im Clinical Development Update
TrivarX advances Stabl-Im toward planned clinical feasibility study
Notice of AGM and Closing Date for Director Nominations
Appendix 4E - Preliminary Final Report
June 2026 Quarterly Activities Report and Appendix 4C
TrivarX appoints new CEO and advances Stabl-Im Phase 1 clinical preparations with product supply secured